MoneyWorks4Me

The total revenue for the quarter ended September 2021 remained nearly unchanged at Rs. 11762.00 millions.A slender decline of -16.82% was recorded to Rs. 1976.30  millions from Rs. 2375.90 millions in the corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 3383.10 millions from 3746.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 11762.00 11273.00 4.34 23968.00 20977.10 14.26 47687.20 27973.40 70.47
Other Income 45.00 65.80 -31.61 120.70 130.60 -7.58 273.20 58.10 370.22
PBIDT 3383.10 3746.50 -9.70 7089.40 6457.10 9.79 15371.90 5760.40 166.85
Interest 205.90 133.70 54.00 456.30 279.30 63.37 659.20 877.10 -24.84
PBDT 3177.20 3612.80 -12.06 6633.10 6177.80 7.37 14712.70 4883.30 201.29
Depreciation 593.30 487.90 21.60 1148.20 964.50 19.05 1966.40 1838.50 6.96
PBT 2583.90 3124.90 -17.31 5484.90 5213.30 5.21 12746.30 3044.80 318.63
TAX 607.60 749.00 -18.88 1287.80 1249.60 3.06 3185.20 374.30 750.98
Deferred Tax -59.60 -62.80 -5.10 114.70 -108.60 -205.62 -164.60 -155.70 5.72
PAT 1976.30 2375.90 -16.82 4197.10 3963.70 5.89 9561.10 2670.50 258.03
Equity 1073.20 1072.00 0.11 1073.20 1072.00 0.11 1073.20 1069.10 0.38
PBIDTM(%) 28.76 33.23 -13.45 29.58 30.78 -3.91 32.23 20.59 56.54
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..